- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06506552
Effects of Inferior Mesenteric Artery Preservation in Laparoscopic Colorectal Resection for Diverticular Disease. (EIMAP)
July 21, 2024 updated by: Francesco Saverio Mari, MD, PhD, FACS, University of Roma La Sapienza
Inferior Mesenteric Artery Preservation in Laparoscopic Colorectal Resection for Diverticular Disease; Short and Long Term Effects in Defecatory Function
This is a prospective randomized study aimed to verifying the short and long-term results of inferior mesenteric artery preservation following colorectal resection for diverticular disease
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
This study wants to demonstrate that the preservation of the inferior mesenteric artery allow to improve postoperative defecatory function and improve patient's quality of life.
Study Type
Interventional
Enrollment (Actual)
300
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- BMI < 35
- ASA I-III
- Hinchey I-III
Exclusion Criteria:
- BMI > 35
- ASA IV
- Hinchey IV
- Previous procedures that could have been modified the nervous mesenteric pattern (surgery, radiotherapy or chemotherapy)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Inferior mesenteric artery preservation
Performing colorectal resection for diverticular disease the IMA was preserved ligating the sigmoids arteries close to colonic wall.
|
Performing left hemicolectomy, sigmoidectomy or rectal resection the IMA was preserved ligating the sigmoids arteries close to the colonic wall
|
|
Active Comparator: Inferior mesenteric ligation
Performing colorectal resection the IMA was sectioned just below the origin of left colic artery.
|
Performing left emicolectomy, sigmoidectomy or rectal resection the IMA is sectioned after the origin of left colic artery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Defecatory disorders
Time Frame: 6 months from surgery
|
the presence of defecatory disorders was evaluated (Costipation, Evacuation frequency,evacuation urgency, fragmented evacuation,flatus incontinence, liquid incontinence)
|
6 months from surgery
|
|
Defecatory disorders
Time Frame: 12 months from surgery
|
the presence of defecatory disorders was evaluated (Costipation, Evacuation frequency,evacuation urgency, fragmented evacuation,flatus incontinence, liquid incontinence)
|
12 months from surgery
|
|
Defecatory disorders
Time Frame: 6 years from surgery
|
the presence of defecatory disorders was evaluated (Costipation, Evacuation frequency,evacuation urgency, fragmented evacuation,flatus incontinence, liquid incontinence)
|
6 years from surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Constipation
Time Frame: 6 months from surgery
|
The incidence and severity of postoperative constipation was evaluated with Cleveland Clinic Constipation Score ( score range from 0 to 30, the higher score defines worse constipation status)
|
6 months from surgery
|
|
Constipation
Time Frame: 12 months from surgery
|
The incidence and severity of postoperative constipation was evaluated with Cleveland Clinic Constipation Score ( score range from 0 to 30, the higher score defines worse constipation status)
|
12 months from surgery
|
|
Constipation
Time Frame: 6 years from surgery
|
The incidence and severity of postoperative constipation was evaluated with Cleveland Clinic Constipation Score ( score range from 0 to 30, the higher score defines worse constipation status)
|
6 years from surgery
|
|
Incontinence
Time Frame: 6 months from surgery
|
The presence of fecal incontinence was evaluated with Cleveland Clinic Incontinence Score( score range from 0 to 20, the higher score defines worse symptoms)
|
6 months from surgery
|
|
Incontinence
Time Frame: 12 months from surgery
|
The presence of fecal incontinence was evaluated with Cleveland Clinic Incontinence Score( score range from 0 to 20, the higher score defines worse symptoms)
|
12 months from surgery
|
|
Incontinence
Time Frame: 6 years from surgery
|
The presence of fecal incontinence was evaluated with Cleveland Clinic Incontinence Score( score ranges from 0 to 20, the higher score defines worse symptoms)
|
6 years from surgery
|
|
Anorectal Muscles function
Time Frame: 6 months from surgery
|
The anorectal muscles function was evaluated with anorectal manometry( sphincter lenght, maximum squeeze pression, resting anal pressure, squeeze duration, maximum pressure sustained)
|
6 months from surgery
|
|
Anorectal Muscles function
Time Frame: 6 years from surgery
|
the anorectal muscles function was evaluated with anorectal manometry ( sphincter lenght, maximum squeeze pression, resting anal pressure, squeeze duration, maximum pressure sustained)
|
6 years from surgery
|
|
Postoperative quality of life
Time Frame: 6 months from surgery
|
the postoperative QOL(quality of life) was evaluated with EORTC-30 tests( European organization for research and treatment of cancer, scores range from 0 to 100; a higher score represents a higher ("better") level of functioning, or a higher ("worse") level of symptoms)
|
6 months from surgery
|
|
Postoperative quality of life
Time Frame: 12 months from surgery
|
the postoperative QOL was evaluated with EORTC-30 tests( European organization for research and treatment of cancer,scores range from 0 to 100; a higher score represents a higher "better" level of functioning, or a higher "worse" level of symptoms
|
12 months from surgery
|
|
Postoperative quality of life
Time Frame: 6 years from surgery
|
The postoperative QOL was evaluated with EORTC-30 tests( European organization for research and treatment of cancer,scores range from 0 to 100; a higher score represents a higher "better" level of functioning, or a higher "worse" level of symptoms)
|
6 years from surgery
|
|
Postoperative quality of life
Time Frame: 12 months from surgery
|
The postoperative QOL was evaluated with EORTC-29 tests (European organization for research and treatment of cancer each question goes from 1 to 4 , the higher score defines worse symptoms)
|
12 months from surgery
|
|
Postoperative quality of life
Time Frame: 6 years from surgery
|
The postoperative QOL was evaluated with EORTC-29 tests (European organization for research and treatment of cancer each question goes from 1 to 4 , the higher score defines worse symptoms)
|
6 years from surgery
|
|
Postoperative quality of life
Time Frame: 6 months from surgery
|
The postoperative QOL was evaluated with EORTC-29 tests (European organization for research and treatment of cancer each question goes from 1 to 4 , the higher score defines worse symptoms)
|
6 months from surgery
|
|
Postoperative quality of life
Time Frame: 6 months from surgery
|
The postoperative QOL(quality of life) was evaluated with SF-36 score (Short form-36 score, each item scored from 0 to 100, the higher scores defines a favorable health state)
|
6 months from surgery
|
|
Postoperative quality of life
Time Frame: 12 months from surgery
|
The postoperative QOL was evaluated with SF-36 score (Short form-36 score, each item scored from 0 to 100, the higher scores defines a favorable health state)
|
12 months from surgery
|
|
Postoperative quality of life
Time Frame: 6 years from surgery
|
The postoperative QOL was evaluated with SF-36 score (Short form-36 score, each item scored from 0 to 100, the higher scores defines a favorable health state)
|
6 years from surgery
|
|
Postoperative surgical complication
Time Frame: 1 month from surgery
|
The incidence of postoperative surgical complications was evaluated
|
1 month from surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2012
Primary Completion (Actual)
January 15, 2024
Study Completion (Actual)
January 20, 2024
Study Registration Dates
First Submitted
July 11, 2024
First Submitted That Met QC Criteria
July 11, 2024
First Posted (Actual)
July 17, 2024
Study Record Updates
Last Update Posted (Actual)
July 23, 2024
Last Update Submitted That Met QC Criteria
July 21, 2024
Last Verified
July 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- DS-056
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Constipation
-
Hamilton Health Sciences CorporationNot yet recruitingConstipation | Constipation - Functional | Constipation AggravatedCanada
-
Peking Union Medical College HospitalInstitute of Process Engineering, Chinese Academy of SciencesNot yet recruitingChronic Constipation | Constipation - Functional | Fecal Microbiota TransplantationChina
-
Singapore Institute of TechnologyNot yet recruitingConstipation | Diet Modification | Constipation-predominant Irritable Bowel Syndrome | Diet Therapy | Constipation - Functional | Constipation Chronic Idiopathic | Constipation, Signs and Symptoms, Digestive | Dietary Fiber | Dietary Fibers | Constipation Predominant Irritable Bowel Syndrome | Dietary and... and other conditionsSingapore
-
usMIMA S.L.CompletedConstipation | Constipation Chronic Idiopathic | Constipation; NeurogenicSpain, United Kingdom
-
Institute of Medical Sciences and SUM HospitalNot yet recruitingFunctional Constipation | Constipation - Functional | Constipation Chronic Idiopathic | Fecal Impaction | Pediatric Functional ConstipationIndia
-
Selin KoşanActive, not recruitingChronic Constipation | Functional Constipation | Pelvic Floor | Biofeedback | Diaphragmatic BreathingTurkey (Türkiye)
-
Peking Union Medical College HospitalRecruitingChronic Constipation | Constipation - Functional | Fecal Microbiota Transplantation (FMT)China
-
SK Life Science, Inc.CompletedChronic Constipation | Functional ConstipationUnited States
-
Hong Kong Metropolitan UniversityNot yet recruitingConstipation | Constipation Drug Induced | Psychiatric Drug Induced ConstipationHong Kong
-
Hong Kong Metropolitan UniversityHospital Authority, Hong KongRecruitingConstipation | Constipation Drug Induced | Psychiatric Drug Induced ConstipationHong Kong
Clinical Trials on IMA preserving
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Shoichi Fujii, MD, PhDUnknownRectal Cancer | Colon Rectal ResectionJapan
-
Wakayama Medical UniversityCompleted
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruiting
-
PfizerCompletedAsthmaUnited States, Canada
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Mansoura UniversityCompletedBehçet's DiseasecasesEgypt
-
Mansoura UniversityUnknownProstatic Hyperplasia | Prostate Disease | BPH With Urinary Obstruction | Prostate Obstruction | Ejaculation AbnormalEgypt